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MIPT3Tumor necrosis factor alpha receptor 3 interacting protein 1 (Traf3ip1), also known as MIPT3, was initially
characterized through its interactions with tubulin, actin, TNFR-associated factor-3 (Traf3), IL-13R1, and
DISC1. It functions as an inhibitor of IL-13-mediated phosphorylation of Stat6 and in sequestration of Traf3
and DISC1 to the cytoskeleton. Studies of the Traf3ip1 homologs in C. elegans (DYF-11), Zebraﬁsh (elipsa),
and Chlamydomonas (IFT54) revealed that the protein localizes to the cilium and is required for ciliogenesis.
Similar localization data has now been reported for mammalian Traf3ip1. This raises the possibility that Tra-
f3ip1 has an evolutionarily conserved role in mammalian ciliogenesis in addition to its previously indicated
functions. To evaluate this possibility, a Traf3ip1 mutant mouse line was generated. Traf3ip1 mutant cells
are unable to form cilia. Homozygous Traf3ip1 mutant mice are not viable and have both neural developmen-
tal defects and polydactyly, phenotypes typical of mouse mutants with ciliary assembly defects. Furthermore,
in Traf3ip1 mutants the hedgehog pathway is disrupted, as evidenced by abnormal dorsal–ventral neural
tube patterning and diminished expression of a hedgehog reporter. Analysis of the canonical Wnt pathway
indicates that it was largely unaffected; however, speciﬁc domains in the pharyngeal arches have elevated
levels of reporter activity. Interestingly, Traf3ip1 mutant embryos and cells failed to show alterations in IL-13
signaling, one of the pathways associatedwith its initial discovery. Novel phenotypes observed in Traf3ip1mu-
tant cells include elevated cytosolic levels of acetylated microtubules and a marked increase in cell size in cul-
ture. The enlarged Traf3ip1 mutant cell size was associated with elevated basal mTor pathway activity. Taken
together, these data demonstrate that Traf3ip1 function is highly conserved in ciliogenesis and is important
for proper regulation of a number of essential developmental and cellular pathways. The Traf3ip1 mutant
mouse and cell lines will provide valuable resources to assess cilia function in mammalian development and
also serve as a tool to explore the potential connections between cilia and cytoskeletal dynamics, mTor regula-
tion, and cell volume control.logy, 1918 University Blvd.,
.
rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Primary cilia are solitary immotile appendages found on nearly all
mammalian cell types where they serve important sensory and signal-
ing roles essential for normal development and adult homeostasis (for
a recent review see (Berbari et al., 2009)). The cilium is assembled
through an evolutionarily conserved process called intraﬂagellar trans-
port (IFT). IFT mediates the bi-directional movement of proteins be-
tween the base and tip of the cilium and is vital for transport of both
structural and signaling components of the cilium. Numerous proteins
are required for assembly of the IFT particle; for example interactionwith kinesin and dynein motor proteins is crucial for the loading and
unloading of cargo destined for delivery to and from the ciliary compart-
ment. Relatively little is known about how the IFT particle is assembled
or regulated in mammalian systems, although genetic and biochemical
studies in model systems such as C. elegans and Chlamydomonas
are providing important insights (for a review on IFT see (Pedersen
and Rosenbaum, 2008)).
Defects in cilia structure or function are associated with multiple
human genetic disorders collectively termed ciliopathies. These dis-
orders exhibit a wide range of clinical features including anosmia, ret-
inopathy, mental retardation, infertility, obesity, cystic kidney
disease, situs inversus, and polydactyly (Sharma et al., 2008). While
the molecular mechanisms contributing to these clinical features re-
main poorly deﬁned, it is thought that the breadth of affected tissues
and organ systems is due to the presence of primary cilia on most
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signaling pathways. Furthermore, cilia contain distinct complements
of signaling machinery depending on the speciﬁc cell types on which
they are found, suggesting that not all cilia are created equal in
their signaling capabilities (Berbari et al., 2009). Although human
ciliopathy patients offer excellent opportunities to study primary
cilia functions, these patients are relatively rare and only a few of the
mutations involve bona ﬁde IFT genes (Arts et al., 2011; Cavalcanti
et al., 2011). Thus, most insights into the molecular functions of cilia
and IFT proteins in humans have been derived from comparative phe-
notypic analyses of genetic models across diverse systems.
There are several signaling pathways such as hedgehog (Hh) and
wingless (Wnt) that have been associated with the cilium. Mutations
in IFT genes or other ciliary proteins result in aberrant regulation of
these pathways. For example, cilia regulate both activator and repressor
functions of the Gli proteins in the Hh pathway. As such, in the absence
of the cilium, the entire pathway becomes deregulated (Houde et al.,
2006; Haycraft et al., 2005; Huangfu et al., 2003; Liu et al., 2005). Cilia
also appear to be important for noncanonical Wnt-mediated suppres-
sion of the canonical Wnt pathway, although involvement of cilia in
the latter has recently been questioned (Gerdes and Katsanis, 2008b;
Ocbina et al., 2009). The cilium has also been implicated as a mechano-
sensor, detecting ﬂuid-ﬂow mediated shear stress across cells in the
renal tubule and endothelium and possibly in bone and chondrocytes
(Haycraft et al., 2007; Nauli et al., 2003, 2008). In addition, the cilium
is required for photoreception in the retina and for chemosensation in
olfaction. Some of the disease phenotypes (e.g. retinal degeneration, an-
osmia, cerebellar hypoplasia, and polydactyly) observed in human cilio-
pathy patients can be explained by defects in the aforementioned
pathways (for a review on ciliopathies see (Sharma et al., 2008)). How-
ever, many have not been associated with defects in any particular
pathway. These data suggest that the cilium is involved in additional
signaling activities that have yet to be determined.
Intriguingly, a protein recently reported to be essential for
ciliogenesis in C. elegans (dyf-11), Zebraﬁsh (elipsa), and Chlamydomonas
(IFT54) was identiﬁed in mammalian systems as tumor necrosis factor
alpha receptor 3 interacting protein 1 (Traf3ip1)/microtubule interacting
protein that associates with Traf3 (MIP-T3, hereinafter called Traf3ip1)
(Kunitomo and Iino, 2008; Li et al., 2008). In contrast to the ciliary/IFT
role for the homologs in lower model organisms, in mammals Traf3ip1
is reported to bindwith IL-13Rα1 and functions to repress IL-13 signaling
by impairing IL-13 induced STAT6 phosphorylation (Niu et al., 2003).
Traf3ip1 has also been shown to regulate functions of proteins such as
Traf3 and DISC1 by sequestration of these factors to microtubules (Niu
et al., 2003). In the case of Traf3, ligand stimulation of cytokine recep-
tors, such as CD40, causes the dissociation of Traf3-MIP-T3 and recruit-
ment of Traf3 to the CD40 receptor (Ling and Goeddel, 2000). Further,
Traf3ip1 was found to bind both actin and tubulin, leading to the spec-
ulation that it is involved in regulating cytoskeletal dynamics (Guo et al.,
2010). More recent data have indicated that Traf3ip1 also localizes to
the cilium inmammalian cell lines (Follit et al., 2009); however, the im-
portance of this localization and its association with the aforemen-
tioned functions is not known. Together, these data raise the
possibility that Traf3ip1 is a multifunctional protein that has an evolu-
tionarily conserved role as a component of the IFT system aswell as ad-
ditional roles in regulating pathways, such as IL-13 and CD40, that have
not previously been associated with the cilium.
Methods and materials
Generation of Traf3ip1 gene trap allele mice
The Traf3ip1 mutant line (Traf3ip1Gt(RRJ005)Byg, BayGenomics, San
Francisco, CA; hereinafter called Traf3ip1GT) was generated using em-
bryonic stem cells in which a β-galactosidase neomycin resistance fu-
sion cassette was inserted into intron 11 of Traf3ip1. The insertionsite was conﬁrmed by genomic PCR and sequence analysis. PCR
primers for genotyping were designed based on the insertion site (se-
quences available upon request). The embryonic stem cells contain-
ing the gene trap were on the 129P2/OlaHsd background and were
injected into C57BL/6 blastocysts using standard procedures. Chi-
meras were then crossed with albino C57BL/6 females and germline
transmission was conﬁrmed by coat color and subsequent PCR geno-
typing. After observing no homozygous mutant offspring, timed preg-
nancies for embryo analysis were performed. Wildtype and Traf3ip1
embryos were generated by intercrossing heterozygous animals and
harvested at the indicated embryonic days with the morning of vagi-
nal plug being embryonic day 0.5 (E0.5).Quantitative real time PCR analysis
Quantitative real-time (qRT) PCR analysis of RNA isolated from
mouse embryonic ﬁbroblasts was performed using iQ SYBR Green
Supermix (Bio-Rad, Hercules, CA, USA) with the CFX96 real-time PCR
detection system (Bio-Rad) as previously reported (Croyle et al.,
2011). The primers for qRT-PCR analysis were generated in the 3
prime end of the Traf3ip1 transcript after the gene trap insertion
(sequences available upon request).Wnt and Hh reporter mice analysis
The activity of the canonical Wnt pathway was analyzed by cross-
ing compound heterozygous reporter [BAT-gal (Tg(BAT-lacZ)3Picc)
(Maretto et al., 2003) or Ptch-Lacz ((Ptch1tm1Mps)(Goodrich et al.,
1997))]; Traf3ip1GT males with Traf3ip1GT heterozygous females.
Embryos from timed pregnancies were dissected at E10.5 and report-
er gene activity in embryos was detected as previously described
(Maretto et al., 2003).Mouse embryonic ﬁbroblast generation
Mouse embryonic ﬁbroblasts (MEFs) were harvested from E9.5
embryos and cultured in DMEM growth medium with High Glucose,
0.05 mg/ml Penicillin/Streptomycin, 2 mM L-Glutamine, 0.2 mM
β-mercaptoethanol, and 10% Fetal Bovine Serum (FBS). Prior to immu-
nolabeling, MEFs were cultured in reduced serum medium containing
0.5% FBS for 48 h to induce primary cilia formation.Expression plasmid construction
The coding sequence of Traf3ip1 was ampliﬁed using Gateway-
compatible primers from reverse-transcribed mouse whole-brain
RNA generated using the Superscript First-Strand Synthesis RT-PCR
Kit (Invitrogen, Carlsbad, CA). PCR ampliﬁcation was performed
with Phusion Taq Polymerase (New England Biolabs, Ipswich, MA).
All DNA constructs were sequence veriﬁed (primer sequences are
available upon request).Cell culture and transient transfections
IMCD-3 cells (ATCC, Manassas, VA) were maintained in DMEM:
F12 medium supplemented with 10% FBS, 1.2 g/l of sodium bicarbon-
ate, and 0.5 mM sodium pyruvate. 5×106 cells were electroporated
with 10 μg of DNA and plated at high density on glass coverslips as
previously described (Berbari et al., 2008). Cells were ﬁxed 24–48 h
post-transfection for immunocytochemistry. MEFs were treated
with mouse recombinant IL-13 (10 ng/ml) from eBioscience for
20 min prior to protein isolation.
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Cells were scraped into ice-cold lysis buffer (137 mMNaCl, 20 mM
Tris pH 8.0, 1% Triton X-100, 10% glycerol, and complete EDTA-free
protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN)).
Cells were disrupted by passage several times through a syringe at-
tached to a 30.5 gage needle. The lysates were incubated on ice for
30 min and vortexed. Protein concentrations were determined by
the Bradford assay (Bio-Rad Laboratories, Hercules, CA). Protein sam-
ples were resolved on a denaturing 10% Tris–HCl gel (Bio-Rad Labora-
tories, Hercules, CA) and transferred to Immobilon-Psq transfer
membrane (Millipore, Billerica, MA). Membranes were blocked in
TBS-T (10 mM Tris–HCl pH 7.5, 150 mM NaCl, 0.1% Tween-20)
with 5% milk for 1 h and incubated with primary antibody diluted in
TBS-T with 2% BSA for 16–24 h at 4 °C. Membranes were probed
with horseradish peroxidase (HRP) conjugated secondary antibodies
diluted in TBS-T with 1% milk for 1 h at room temperature. Secondary
antibodies were detected using SuperSignal West Pico Chemilumi-
nescent Substrate (Pierce, Waltham, MA) and bands were visualized
using Blue Ultra Autorad Film (Bioexpress ISC). The following primary
antibodies and dilutions were used: anti-S6 (#2317) 1:1000, anti-p-S6
Ser240/244 (#2215) 1:1000, anti-p-S6 Ser235/236 (#2211) 1:1000,
anti-p70S6K, (#9202) 1:1000, anti-p-p70S6K (#9205) 1:1000, anti-
STAT6 (#9362) 1:1000, anti-pSTAT6 (#9361) 1:1000 (Cell Signaling,
Beverly, MA), anti-acetylated α-tubulin (T7451) anti-gamma tubulin
(T6557) (Sigma, St. Louis, MO) 1:1000, anti-GM130 (gift from
Dr. Elizabeth Sztul) 1:1000 and anti-α-tubulin (ab18251 Abcam,
Cambridgeshire, UK) 1:1000. Secondary antibodies were HRP conjugat-
ed anti-rabbit (#31460) 1:5000, HRP conjugated anti-mouse (#31430)
1:10,000 (Pierce/Thermo Scientiﬁc, Waltham, MA). Band density was
determined using the ImageJ software (NIH).
Flow cytometry
Single cell suspensions of MEF cultures were generated by trypsin
treatment to release the cells followed by a media wash with 20% FBS
to quench the tryptic digestion. Cells were then centrifuged and
resuspended in PBS with 2% FBS. Cells were gated on total live cells
(Propidium Iodide negative) and relative forward scatter (FSC) was
determined. All ﬂow cytometry analyses were performed on aA B
ED
Traf3IP1-GFP
Traf3IP1-GFP
Acetyla
Fig. 1. Traf3ip1-GFP expressed in IMCD3 cells localizes to both the cilia axoneme and the b
marker (B, C) acetylated α-tubulin. (D) Traf3ip1-GFP co-localizes with (E, F arrows) the baFACSCalibur (BD Biosciences, Franklin Lakes, NJ) and analyzed using
FlowJo software (Tree Star, Ashland, OR).
Immunoﬂuorescence
Cells were ﬁxed in 4% paraformaldehyde and permeabilized with
0.3% Triton X-100 in PBS with 2% donkey serum, 0.02% sodium
azide and 10 mg/ml bovine serum albumin (BSA). Cells were labeled
with anti-acetylated α-tubulin, 1:1000 (T-6793; Sigma-Aldrich,
St. Louis, MO), anti-Arl13b, 1:1000 (gift of Dr. Tamara Caspary, Emory
University), anti-IFT20, 1:500 (gift of Dr. Greg Pazour, University of
Massachusetts) and the following antibodies from Developmental
Studies Hybridoma Bank (University of Iowa, Iowa City, IA): anti-
ShhN (5E1), anti-Nkx6.1, 1:100 (F65A2), anti-Mnr2, 1:100 (81.5C10),
and anti-Msx1+2, 1:100 (4 G1). All incubations and washes were car-
ried out in PBS with 2% normal donkey serum, 0.02% sodium azide
and 10 mg/ml BSA. Primary antibody incubations were performed for
16–24 h at 4 °C and secondary antibody incubations were performed
for 1 h at room temperature. Secondary antibodies included: Alexa
Fluor-546 conjugated donkey anti-mouse IgG (Invitrogen, Carlsbad,
CA), and Alexa Fluor 488-conjugated donkey anti-goat IgG (Invitrogen,
Carlsbad, CA). Nuclei were visualized by Hoechst nuclear stain
(Invitrogen, Carlsbad, CA). Coverslips were mounted using Immu-
Mount (Fisher Scientiﬁc, Pittsburgh, PA).
Confocal microscopy
All ﬂuorescence images were captured on Perkin Elmer ERS 6FE
spinning disk confocal microscope and images were processed and
analyzed in Volocity version 5.3 software (Perkin Elmer, Shelton, CT).
Results
To assess Traf3ip1 subcellular localization and to explore con-
served function, we expressed Traf3ip1 as a GFP fusion in mouse
inner-medullary renal collecting duct cells (IMCD3). Localization of
Traf3ip1-GFP was observed in both the cilia axoneme (Fig. 1A inset)
as well as at the basal body (Fig. 1A–F), consistent with previous re-
ports (Follit et al., 2009; Li et al., 2008). Cytosolic GFP localization
was also evident, which may be an artifact of overexpression of theF
C
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asal body. (A, C) Traf3ip1-GFP co-localizes with the cilia axoneme (arrows and insets)
sal body marker gamma tubulin. Hoechst nuclear label in blue. Scale bar 14 μm.
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dogenously expressed Traf3ip1 using afﬁnity puriﬁed antiserum
(Kunitomo and Iino, 2008).
To explore the possible roles of Traf3ip1, as well as its putative
conserved function as an IFT protein, a Traf3ip1 mutant mouse line
was created using an embryonic stem cell line harboring a gene trap
(Traf3ip1GT) insertion in intron 11 of Traf3ip1 (Fig. 2A). From more
than ten Traf3ip1GT heterozygous intercrosses yielding more than
100 offspring no viable Traf3ip1GT homozygous mutant mice were
obtained indicating that loss of Traf3ip1 function is lethal. Further-
more, real-time quantitative PCR analysis (qRT) in Traf3ip1GT mouse
embryonic ﬁbroblasts (MEFs) showed near 90% reduction in tran-
script levels (Fig. 2B) compared to wildtype MEFs. Analysis ofWild-Type Traf3IP1 Allele(Traf3IP1WT)
Traf3IP1 Gene Trap Allele (Traf3IP1GT)
β-geo
A
G
C
E
B
Fig. 2. Traf3ip1 mutant mice are embryonic lethal and display phenotypes typically associate
Traf3ip1 mutant gene trap allele (Traf3ip1GT). (B) Real-time reverse transcriptase PCR resul
bryonic ﬁbroblasts. Expression levels are normalized to the internal control levels of GAP
(D) Traf3ipGT mutant embryos at day 10.5 (E10.5) show signiﬁcant neural developmental defe
embryos on the left and Traf3ip1GTmutant embryos on the right. (E, arrow) Signiﬁcant cardiac
associated with E10.5 Traf3ip1GT mutant embryos. (F) A polydactylous forelimb of an embryonembryos from timed pregnancies indicated homozygous Traf3ip1GT
mutants are embryonic lethal with none developing past E13.5. How-
ever, near-Mendelian ratios were observed at E10.5 (23 wildtype;
66 Traf3ip1GT heterozygotes; 22 Traf3ip1GT homozygotes). This vari-
ability may be due to the remaining low-level expression of Traf3ip1
in the gene trap allele or inﬂuences of the genetic background
(129/Ola and C57BL/6).
Analysis of the mutant embryos revealed several phenotypes com-
monly associated with cilia abnormalities including neural develop-
mental defects (Fig. 2C, D, G), cardiac edema (Fig. 2E), and
polydactyly (Fig. 2F). Microphthalmia was also observed in several
mutant embryos (Fig. 2D arrow). Taken together, these data show
that the Traf3ip1GT allele causes embryonic lethality and results in aD
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cts as well as (D, arrow) microphthalmia in the Traf3ip1GT mutant. (E and G) Traf3ip1WT
edema is observed in the embryonic day 13.5mutant embryo. (G) A curled tail phenotype
ic day 13.5 Traf3ip1GT mutant embryo.
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trap allele does disrupt most of the Traf3ip1 function and in general
the phenotypes agree with those reported in other IFT and cilia mu-
tant mice.
Data from multiple lower eukaryotic systems suggest that Traf3ip1
is essential for cilia formation (Li et al., 2008). To directly test the hy-
pothesis that Traf3ip1 plays an evolutionarily conserved role in cilio-
genesis, Traf3ip1GT homozygous mutant cells and embryos were
immunolabeled with cilia markers. Labeling of serum-starved, pri-
mary mouse embryonic ﬁbroblasts (MEF) from Traf3ip1GT and con-
trol mice with acetylated α-tubulin (Fig. 3A, B) and sections from
E10.5 embryos with the cilia marker Arl13b (Fig. 3E, F) indicated
that the mutants have a marked reduction in the number of cilia
both in vitro and in vivo.
In previous studies, it was shown that overexpression of Traf3ip1 in
mammalian cells caused displacement of IFT20 from the Golgi (Follit
et al., 2009). Thus, we analyzed whether loss of Traf3ip1 may also
alter IFT20; however, immunoﬂuorescence analysis showed no signiﬁ-
cant differences in IFT20 localization (Supplemental Fig. 1A, B) (Follit
et al., 2009). Taken together, the localization of Traf3ip1 protein
(Fig. 1), the mutant phenotype (Fig. 2), and the absence of cilia on mu-
tant cells (Fig. 3) indicate that Traf3ip1 plays a conserved role in mam-
malian ciliogenesis.
A striking observationmade in Traf3ip1GTmutant cells was the sub-
stantial increase in the levels of cytosolic acetylated α-tubulin in cell
lines (Fig. 3 and Supplemental Fig. 1). These effects were observed
in multiple independent embryonic ﬁbroblast lines isolated from
the Traf3ip1mutants. To further assess the cause of the increase in acet-
ylated α-tubulin, protein lysates were isolated from the MEFs and ana-
lyzed by western blot. The data indicated that there were no changes
in total tubulin levels but rather an overall increase in acetylation
(Fig. 3C, D) when compared to GAPDH. To determine if similar effects
occurred in vivo, sections of E10.5mutant embryowere immunolabeled
with anti-acetylated α-tubulin. Interestingly, this phenotype was onlyD
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Fig. 3. Traf3ip1 cells fail to form cilia both in vitro and in vivo and have elevated levels of ace
ﬁbroblast (MEF) cells in culture fail to form primary cilia as observed by acetylated α-tubul
size and acetylated α-tubulin levels in Traf3ip1GT mutants, compared to control cells. (C)
western blot and quantitated by densitometry analysis. (D) Traf3ip1WT and Traf3ip1GT m
(E and F) For in vivo analysis, E10.5 embryo sections were immunolabeled for the cilia ma
of a Traf3ip1WT embryo while there is a near complete loss in this tissue of the Traf3ip1GT m
α-tubulin in green with Traf3ip1WT and a Traf3ip1GT mutant. Scale bars 14 μm in A, B andobserved in certain regions of the embryo. For example, in the lateral
plate mesenchyme, which is ciliated at this time (Fig. 3E, F), there did
not appear to be higher levels of acetylated α-tubulin staining by im-
munoﬂuorescence; however, in the neural tube of Traf3ip1GT mutants
there was an increase in acetylated α-tubulin when compared to
Traf3ip1WT sections (Fig. 3G, H). Although the cause of the increased
acetylation is unknown, the data indicate that loss of cilia may en-
hance cytosolic microtubule stability or increase the activity or mi-
crotubule access to an acetyl-transferase.
In addition to increased microtubule acetylation, embryonic ﬁbro-
blasts from Traf3ip1GT mutants were signiﬁcantly larger as deter-
mined by confocal ﬂuorescence microscopy and ﬂow cytometry
(Fig. 3B, D). In contrast to the microtubule acetylation data, this effect
appears to be observed only under in vitro conditions. The cause of
the discrepancy between the in vitro and in vivo data is currently un-
known. Cell size control is a complex process involving the integra-
tion of nutrient status and growth factors in the cells' environment.
In part, cell volume is regulated through the mammalian target of
rapamycin (mTor) pathway. Furthermore, recent data have demon-
strated a link between cilia dysfunction in cystic kidney disease
mouse and cell culture models and regulation of mTorC1 activity
that subsequently inﬂuences cell size (Boehlke et al., 2010; Bonnet
et al., 2009; Hartman et al., 2009). To further investigate this connec-
tion, we compared the mTor pathway activity in the Traf3ip1GT mu-
tant and control cells both in vivo and in vitro. In the absence of
serum Traf3ip1GT mutant and wildtype MEFs showed basal levels of
phospho-mTor (p-mTor) and had similar low levels of phospho-
p70S6 kinase (p-p70 S6K), the direct downstream target of mTor
(Fig. 4A and Supplemental Fig. 2A). Both mutant and control MEFs
showed a response to pathway activation after only 5 min of serum
treatment (Fig. 4A, B) which was still seen after 1.5 and 3 h treatment
(Supplemental Fig. 2B). Serum induced activation of the mTor path-
way could be equally impaired in control andmutant cells by addition
of rapamycin (Supplemental Fig. 2A). Quantiﬁcation of the data fromE F
Arl13b Arl13b
G HTraf3IP1WT
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Fig. 4. Traf3ip mutant cells display an elevated mTor response to serum. (A) Traf3ip1WT and Traf3ip1GT mutant MEF cells were cultured for 48 h with no serum and then exposed to
serum for 5, 10, and 30 min prior to total protein isolation and western blotting for the following mTor pathway proteins and their phosphorylated forms: phospho-mTor (p-mTor),
total mTor (mTor), phospho-p70 S6 kinase (p-p70 S6K), total p70 S6 kinase (p70 S6K), phospho-PRAS40 (p-PRAS40), total PRAS40 (PRAS40), phospho-S6 ribosomal protein serines
235/236 (p-S6 235/236), phospho-S6 ribosomal protein serines 240/244 (p-S6 240/244), total S6 ribosomal protein (S6), and loading control the Golgi marker GM130 (GM130).
(B) Densitometry analysis of the serum time course, results for fold changes between the total protein and its phosphorylated form(s), are shown for mTor, PRAS40, p70S6 Kinase,
S6 ribosomal protein both the serine phosphorylation at sites 235/236 and 240/244.
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was generally more dramatic and prolonged in the Traf3ip1GT mu-
tants compared to the control MEF cells. This is shown by the ele-
vated levels of phosphorylated mTor, p70 S6 kinase (p-p70 S6K),
PRAS40 (p-PRAS40), and ribosomal protein S6 (p-S6 235/236)
(Fig. 4B and Supplemental Fig. 2C). Interestingly, serum induced in-
creases in p-S6 ribosomal proteinwas not evidentwith antibodies recog-
nizing p-S6 240/244. Overall, these data suggest that the mTor pathway
is differentially regulated and hyper-responsive in the Traf3ip1GTmutant
cells in vitro and that Traf3ip1GT mutant cells may have a prolonged
response due to impaired down-regulation of the pathway after
stimulation.
In contrast to the acetylated microtubule data, our in vivo analysis
of mTor activity using phospho-S6K levels in Traf3ip1 mutant embry-
os did not show signiﬁcant differences compared to the controls
(Supplemental Fig. 2D). This is in agreement with the similar cell
size observed in vivo in the mutant and control embryos. Taken to-
gether, these results suggest that altered mTor signaling may play arole in the increased cell size observed in Traf3ip1GT mutant MEFs
and that the effect is a differential response between ciliated and
non-ciliated cells in the serum-rich environment of cell culture that
may not be present in vivo.
The cilium has also been implicated in the normal regulation of sev-
eral other important signaling pathways, and defects in these pathways
help explain several of the phenotypes observed in human ciliopathy
patients. In particular,micewithmutations in cilia proteins have defects
in Hh signaling (Houde et al., 2006; Haycraft et al., 2005; Huangfu et al.,
2003; Liu et al., 2005). Similarly, our analysis of Traf3ip1GT mutant em-
bryos suggest they also have defects related to Hh signaling, as evi-
denced by polydactyly (as seen in the few embryos that survive to
E12.5 and E13.5) as well as abnormalities in neural tube closure and
dorsal–ventral patterning. Traf3ip1GT mutant neural tubes showed a
loss of Hh expression in the ﬂoor plate (Fig. 5A, B) and exhibited a dor-
salization phenotype. Evaluation of neural tube domains was per-
formed by immunolabeling for the Hh responsive transcription factors
Nkx6.1 (Fig. 5C, D) and Mnr2 labeling (Fig. 5E, F). The Nkx6.1 domain
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Nkx6.1 Nkx6.1
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Msx Msx
Traf3IP1WT Traf3IP1GT
Fig. 5. Traf3ip1 mutant embryos have abnormalities in neural tube patterning consis-
tent with defects in cilia mediated Hh signaling. (Left column) Traf3ip1WT neural
tube sections and (Right column) Traf3ip1GT mutant sections. (A and B) Sonic Hh label-
ing of the ﬂoor plate is absent in the Traf3ip1GT mutant embryo when compared to its
Traf3ip1WT littermate. (D and F) Sonic Hh responsive compartments are either absent
or greatly diminished in Traf3ip1GT mutant embryos stained for Nkx6.1 or MNR2 when
compared to (C and E) Traf3ip1WT littermates. (G and H) The roof plate marker MSX is
expanded in Traf3ip1GT mutants compared to Traf3ip1WT.
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absent. Furthermore, expression of the roof plate marker Msx is ex-
panded ventrally in Traf3ip1GT mutant neural tubes (Fig. 5G, H). In
order to directly test if Hh signaling is affected in Traf3ip1GT mutants,
the Hh reporter mouse line Ptch-lacz was utilized. β-galactosidase
staining on whole-mount embryos showed a dramatic reduction in
both the neural and endoderm tubes in E10.5 Traf3ip1GT mutant em-
bryos when compared to Traf3ip1WT littermates (Fig. 6A–D). Further-
more, sections of caudal neural tube displayed near absence of
staining (Fig. 6F). Collectively, the localization data, the loss of cilia,
and the phenotype of themutants support a role for Traf3ip1 as amem-
ber of the IFT particle (complex B) as has been previously suggested
through biochemical analysis in mammalian cells (Follit et al., 2009)
and through studies of the homologs in lower eukaryotes (Li et al.,
2008).
Activity of the Wnt pathway has also been associated with cilia.
Previous data has shown that cilia are important for modulating the
balance between canonical and non-canonical Wnt signals and that
in the absence of cilia the level of canonical signaling is elevated
(for a review see (Gerdes and Katsanis, 2008b)). To assess whether
Traf3ip1GT mutant embryos show defects in canonical Wnt signaling,
we crossed the Traf3ip1GT mutation onto the BAT-gal Wnt reporter
mouse line (Maretto et al., 2003). Traf3ip1GT mutant embryos did
not show overt differences in the BAT-gal reporter expression com-
pared to littermates. One exception was observed in the elevated re-
porter expression in the brachial arches and eye ﬁeld compared to
controls at embryonic day 10.5 (Fig. 7A, B, Supplemental Fig. 3A–F;
arrows in B indicate ectopic Wnt reporter).
The interleukin-13 (IL-13) pathway has been associated with
Traf3ip1, where it was identiﬁed as a factor interacting with the in-
terleukin-13 receptor alpha 1 (Niu et al., 2003). To investigate whether
Traf3ip1 and possibly the cilium are involved in IL-13 signaling activity,
Traf3ip1GT mutant and control MEFs were stimulated with IL-13 and
the downstream readout of STAT6 phosphorylation was assessed by
western blot. The data indicate there are no differences in the resting
or stimulated phospho-STAT6 levels between wildtype and Traf3ip1GT
mutant cells (Fig. 8A). Similarly, whole embryo lysates taken at E10.5
also show no changes in baseline levels of phospho-STAT6 between
mutants andwildtypes (Fig. 8B). These data suggest that there are no al-
terations in IL-13 signaling in Traf3ip1GT mutant MEFs and embryos;
however, they do not rule out a role for Traf3ip1 in IL-13 signaling in
adult tissues.
Discussion
Previous data have indicated that Traf3ip1 is in a complex involved
in regulating numerous signaling pathways, such as IL-13 and CD40
(Ling and Goeddel, 2000; Niu et al., 2003). Traf3ip1 mediates its effects
on these pathways through interactionwith IL-13Rα1 and Traf3 respec-
tively. In previous studies, Traf3ip1 has been shown to inhibit IL-13-
induced phosphorylation of STAT6. Traf3ip1 also forms a microtubule
attached complex with Traf3 which is released to associate with CD40
receptor upon ligand binding (Ling and Goeddel, 2000; Niu et al.,
2003). Traf3ip1 also appears to have a similar function with the protein
Disrupted in Schizophrenia 1(DISC1) which associates with microtu-
bules in a Traf3ip1 dependent manner; the signiﬁcance of the Traf3ip1
interactionwithDISC1 is not known (Morris et al., 2003).More recently,
data from Traf3ip1 homologs in C. elegans, Chlamydomonas and Zebra-
ﬁsh suggest that it is important for ciliogenesis as a component of the
IFT particle (Kunitomo and Iino, 2008; Li et al., 2008; Omori et al.,
2008). Furthermore, support for this possibilitywas provided by the an-
alyses of ciliary proteomes, by the localization of Traf3ip1 in the cilium
of mammalian cells and by immunoprecipitation of Traf3ip1 with com-
plex B IFT proteins (Follit et al., 2009); however, the requirement for
Traf3ip1 inmammalian ciliogenesis and its role inmammalian develop-
ment was not known. We sought to directly address some of these
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D
Fig. 6. Traf3ip1 mutant embryos display changes in the activity of the Ptch-lacZ Hedgehog reporter. β-galactosidase X-gal staining of Ptch-lacZ Hedgehog reporter mice showed
different levels of expression between (A, C, E) Traf3ip1WT and (B, D, F) Traf3ip1GT mutant embryonic day 10.5 embryos. (B and D) The Traf3ip1GT whole mount mutant embryos
show a similar pattern of expression though it is much reduced in both the neural and endoderm tubes (indicated by arrow and arrowhead respectively in panel D). (F) Also in
60 μm thick sections of the caudal neural tube staining is nearly absent in Traf3ip1GT mutant embryos.
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Fig. 7. Traf3ip1 mutant embryos do not display major changes in the activity of the BAT-gal Wnt reporter. (A and B) β-galactosidase X-gal staining of BAT-gal Wnt reporter mice
showed similar patterns between Traf3ip1WT and Traf3ip1GT mutants embryos at embryonic day 10.5.
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evolutionarily conserved role in cilia formation andwhether it regulates
cilia mediated signaling activities.
Indeed, Traf3ip1GT mutant mice are embryonic lethal and pheno-
copy several other cilia mutants in that they display similar neural
tube patterning defects, polydactyly, cardiac edema as well as micro-
phthalmia (Goetz and Anderson, 2010). In addition, cell lines derived
from the mutants demonstrate they are unable to form cilia, conﬁrm-
ing an evolutionarily conserved function likely as an IFT protein. A
role in cilia formation is also supported through analysis of signaling
pathways which are impaired due to loss of Traf3ip1. Data from mul-
tiple laboratories have shown that both the Hh andWnt pathways re-
quire the cilium for proper execution of mammalian development
(Corbit et al., 2008; Gerdes and Katsanis, 2008a; Gerdes and Katsanis,
2008b; Gerdes et al., 2007; Haycraft et al., 2005; Huangfu et al., 2003;
Wiens et al., 2010). Similar to other IFT mutants, Traf3ip1GT mutant
mice displayed defects in Hh-dependent dorsal–ventral neural tube
patterning and exhibited polydactyly indicative of cilia mediated Hh
signaling defects. With regards to canonical Wnt signaling, we
detected only subtle changes in spatial BAT-gal reporter gene activity.
This result was in direct contrast to data reported in several other
studies, but largely agrees with ﬁndings by Ocbina et al. (Ocbina et
al., 2009) analyzing several additional mouse mutants in IFT proteins.
Similar subtle changes in the BAT-gal Wnt reporter in cilia mutants
have also been recently observed by Lancaster et al. (Lancaster et
al., 2011) suggesting that cilia mutants in general may have subtle
in vivo alterations in Wnt activity. It remains to be determined
whether the Wnt reporter changes observed in the Traf3ip1 mutant
are a direct result of Traf3ip1/cilia loss or secondary to other changes,BA
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Fig. 8. Traf3ip1 mutants do not show changes in IL-13 signaling in vitro or in vivo.
(A) No changes of the IL-13 downstream response as indicated by phosphorylation of
STAT6 in Traf3ip1GT mutant (GT) MEFs treated with recombinant IL-13 compared to
wildtype (WT). (B) No difference in baseline IL-13 signaling between wildtype (WT)
and Traf3ip1GT mutant (GT) E10.5 protein lysates.such as mispositioning of cells. This becomes particularly relevant in
the brachial arches in light of the craniofacial and neural crest defects
associated with cilia dysfunction (Brugmann et al., 2010; Tobin et al.,
2008). Furthermore, the subtle nature of the reporter changes in the
Traf3ip1 mutants does suggest that Wnt signaling is largely intact
and unperturbed at this embryonic stage of development.
Based on the analyses of the Traf3ip1 homologs in several lower
eukaryotic organisms, the inability of Traf3ip1GT mutant mammalian
cells to form cilia was not unexpected. However, it was surprising to
ﬁnd that mutant cells displayed a marked increase in cell size,
which to our knowledge has not been reported previously as a conse-
quence of cells lacking a cilium. One possible mechanism would be an
alteration in mTor activity. The mTor pathway has essential roles in
protein translation, proliferation, and is a major inﬂuence on cell
growth and size regulation. Indeed, our analysis of p70S6K and pS6
(235/236) levels, downstream targets of mTor kinase activity, did
conﬁrm increased mTor signaling activity. In fact, Traf3ip1GT mutants
appear to display increased and prolonged sensitivity to stimulation
compared to controls upon serum addition to the growth medium.
This activation could be blocked by rapamycin, an inhibitor of mTor.
Although our data do not provide a deﬁnitive link between mTor
and the increased cell size observed in Traf3ip1GT mutant MEFs, the
data indicate that loss of Traf3ip1 alters the strength of the cell's re-
sponsiveness to stimuli that activate the mTor pathway. However,
we did not observe consistent changes in mTor signaling in vivo in
Traf3ip1 mutant embryos. This could have been the result of either
the cell size phenotype being more subtle in vivo and therefore less
identiﬁable, or perhaps the potential for a size change is exacerbated
under in vitro conditions. Interestingly, it has been suggested that
mTor signaling during embryonic development is much more plastic
as there appears to be decoupling of some downstream pathways as
well as tissue-speciﬁc effects [for a review of mTor signaling in devel-
opment see (Hwang et al., 2008)].
One interesting observation from the mTor data is the differential
effect on phosphorylation of S6 ribosomal protein at serine residues
240/244 versus 235/236. The signiﬁcance of this observation in the
cilia mutants remains unknown, but differential phosphorylation
has long been observed (Mutoh et al., 1992; Palen and Traugh,
1987). In fact there is evidence to suggest that S6 kinase is not the
only kinase that acts on ribosomal S6 [For a review on S6 ribosomal
protein phosphorylation see (Ruvinsky and Meyuhas, 2006)]. There
is now even data suggesting that casein kinase 1 may preferentially
phosphorylate S6 ribosomal protein at the latter serine residues, par-
ticularly serine 247 (Hutchinson et al., 2011). The effects of speciﬁc
75N.F. Berbari et al. / Developmental Biology 360 (2011) 66–76phosphorylation events of S6 ribosomal protein on cell size remain an
interesting avenue of investigation. However, it is interesting to note
that the knock-in mouse model of a complete phospho-null S6 ribo-
somal protein leads to a decrease in size in cell types such as MEFs
(Ruvinsky et al., 2005).
Defects in normal regulation of mTor could also contribute to some
of the phenotypes in human ciliopathy patients. For example, a connec-
tion between the cilium and the mTor pathway has been reported
for polycystin-1 and tuberous sclerosis-2 (Tsc2). Polycystin-1 is a large
ciliary transmembrane protein that interacts with tuberous sclerosis
complex, which normally functions to inhibit mTor activity (Dere
et al., 2010). Deletion of Tsc2 or polycsytin-1 leads to renal cystic disease
that is associated with a marked increase inmTor activity. Interestingly,
the renal cystic phenotypes observed in cilia protein mutant models
such as the orpk (Ift88Tg737Rpw) mice and mice lacking the basal body
protein Oral–Facial-Digital type I (OFDI) can be greatly diminished by
treatment with rapamycin (Zullo et al., 2010).
Another surprising ﬁnding in the Traf3ip1GT mutants both in vitro
and in vivo was the increase in the levels of acetylated α-tubulin in
the cytosol. Whether this reﬂects the mislocalization of a modifying
enzyme normally resident in the cilium, loss of activity of the deace-
tylase caused by ciliary defects, or an overall change in microtubule
stability is not yet known. Also, it is possible that the loss of Traf3ip1
in mutant cells alters stability of the cytoskeleton that contributes to
the changes in cell size observed in culture. Furthermore, it is intrigu-
ing that previous data have shown that Traf3ip1 interacts with both
actin and tubulin leading to the speculation that Traf3ip1 has a role
in cytoskeletal dynamics. Our data indicates that this is likely the
case as cytoskeletal modiﬁcations associated with stabilized microtu-
bules are markedly increased in the Traf3ip1 mutants.
Unlike most cilia proteins, Traf3ip1 was not discovered via analy-
sis of a cilia proteome, a model organism, or ciliopathy patients. Con-
sequently, a body of work regarding Traf3ip1 function existed prior to
its identiﬁcation as a cilia protein. It is feasible that Traf3ip1 mediates
its effects on IL-13 and CD40 signaling or DISC1 activity via localiza-
tion of the receptors and pathway components to the cilium and
that these represent novel pathways requiring cilia for normal regula-
tion. Previous localization studies appear to be performed under con-
ditions where cells are not adequately ciliated and thus localization in
the cilium could be missed. Although there is a good deal already
known about the IFT particle proteins based on studies conducted in
lower eukaryotic systems, there is remarkably sparse information
about potential cargo transported by the raft, particularly those that
associate directly with a known raft component. In addition, it is un-
certain as to why there are so many complex B proteins in the IFT par-
ticle leading to speculation that particular IFT proteins may be
involved in transport of speciﬁc cargo. Alternatively, it remains feasi-
ble that Traf3ip1 will have additional roles outside of the cilium that
involve interactions and sequestration of factors to the cytoskeleton
through its microtubule association. With the generation of this mu-
tant allele it should now be feasible to evaluate some of these possi-
bilities in both in vivo and in vitro context.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2011.09.001.
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